Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
464.4 INR | +3.63% |
|
+6.62% | +28.59% |
06-12 | Solara Active Pharma Sciences Closes INR4.50 Billion Rights Issue | MT |
05-29 | Solara Active Pharma Sciences Limited Re-Affirms Earnings Guidance for the Fiscal Year 2025 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.59% | 257M | |
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Solara Active Pharma Gets Zero Observations from US FDA for Andhra Pradesh, India Unit